Board of Directors
The PMC board of directors is dedicated to supporting the Coalition’s work to promote the understanding and adoption of personalized medicine concepts, services, and products.
Board Vice Chair
Sarah Hersey, PhD, MBA, RAC
Vice President, Head Precision Medicine, Bioanalytical & Translational Sciences, Bristol Myers Squibb
Board Secretary
Brian Caveney, M.D.
President, Biopharma Laboratory Services & Chief Medical and Scientific Officer
Okan Ekinci, MD, MBA
Global Head of Digital Technology and Chief Medical Information Officer, Roche Information Solutions
Megan P. Hall, PhD
Vice President of Medical & Corporate Affairs and Distinguished Scientist, GRAIL, Inc.
Liam Lee, PhD, MB(ASCP)
Franchise Head, Medical Diagnostics US Medical Affairs, Oncology, AstraZeneca
Kristin Ciriello Pothier
Principal, US and Americas Region Life Sciences Sector Leader and Global Deal Advisory and Strategy Leader, Healthcare and Life Sciences KPMG
Anthony Sireci, MD, MSc
Senior Vice President of Clinical Biomarkers, Laboratories and Diagnostics, Eli Lilly and Company
Andrea Stevens, Ph.D.
Interim Head, Global Commercial Precision Medicine, Johnson & Johnson Innovative Medicine
Apostolia M. Tsimberidou, M.D., Ph.D.
Professor, Department of Investigational Therapeutics, The University of Texas MD Anderson Cancer Center












